According to Mesa Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 302.941. At the end of 2022 the company had a P/E ratio of -594.
Year | P/E ratio | Change |
---|---|---|
2022 | -594 | -365.96% |
2021 | 223 | -137.37% |
2020 | -597 | -406.48% |
2019 | 195 | 153.38% |
2018 | 76.9 | -156.3% |
2017 | -137 | -450.52% |
2016 | 39.0 | -5.22% |
2015 | 41.1 | 64.34% |
2014 | 25.0 | -23.9% |
2013 | 32.9 | 59.44% |
2012 | 20.6 | 19.93% |
2011 | 17.2 | -4.85% |
2010 | 18.1 | 1.41% |
2009 | 17.8 | 53.77% |
2008 | 11.6 | -29.54% |
2007 | 16.4 | -5.35% |
2006 | 17.4 | -0.04% |
2005 | 17.4 | 2.02% |
2004 | 17.0 | 12.92% |
2003 | 15.1 | 45.89% |
2002 | 10.3 | 1.54% |
2001 | 10.2 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 37.4 | -87.67% | ๐บ๐ธ USA |
Ametek AME | 32.0 | -89.42% | ๐บ๐ธ USA |
General Electric GE | 18.9 | -93.78% | ๐บ๐ธ USA |
Danaher DHR | 30.6 | -89.89% | ๐บ๐ธ USA |
3M MMM | -6.87 | -102.27% | ๐บ๐ธ USA |
Steris STE | 165 | -45.39% | ๐ฎ๐ช Ireland |
Rockwell Medical
RMTI | -1.70 | -100.56% | ๐บ๐ธ USA |
Bruker BRKR | 37.7 | -87.55% | ๐บ๐ธ USA |
AngioDynamics ANGO | 36.5 | -87.95% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.